The publication “Guidelines formanaging Alzheimer’s Disease”,1suggests that a treatment plan should be developed when the diagnosis has been made.This plan should include: pharmacological therapy (with cholinesterase inhibitor totemporarily improve cognition or slow the rate of cognitive decline), managing possibleco-morbidity, treatment of behavioral symptoms and mood disorders and finally supportfor patients and their relatives. This evidence concerns the gene BCHE and Alzheimer disease.